HF Advisory Group LLC Sells 1,959 Shares of Veeva Systems Inc. $VEEV

HF Advisory Group LLC decreased its holdings in shares of Veeva Systems Inc. (NYSE:VEEV) by 58.4% during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 1,395 shares of the technology company’s stock after selling 1,959 shares during the period. HF Advisory Group LLC’s holdings in Veeva Systems were worth $398,000 as of its most recent SEC filing.

A number of other large investors have also recently made changes to their positions in the business. Burkett Financial Services LLC bought a new stake in shares of Veeva Systems during the third quarter worth about $27,000. SHP Wealth Management acquired a new position in Veeva Systems during the 4th quarter valued at about $26,000. MV Capital Management Inc. bought a new stake in Veeva Systems during the 4th quarter worth approximately $30,000. Reflection Asset Management purchased a new stake in shares of Veeva Systems in the fourth quarter worth approximately $32,000. Finally, Compass Financial Management LLC bought a new position in shares of Veeva Systems in the second quarter valued at approximately $27,000. 88.20% of the stock is owned by institutional investors.

Insider Activity

In related news, insider Thomas Schwenger sold 10,000 shares of the firm’s stock in a transaction that occurred on Thursday, August 27th. The shares were sold at an average price of $281.33, for a total value of $2,813,300.00. Following the completion of the transaction, the insider directly owned 19,449 shares of the company’s stock, valued at approximately $5,471,587.17. This trade represents a 33.96% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, EVP Daniel Rizzo sold 4,841 shares of Veeva Systems stock in a transaction that occurred on Friday, October 2nd. The shares were sold at an average price of $276.51, for a total transaction of $1,338,584.91. Following the completion of the transaction, the executive vice president owned 7,665 shares of the company’s stock, valued at $2,119,449.15. This represents a 38.71% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Insiders have sold a total of 51,591 shares of company stock valued at $13,355,945 over the last quarter. Company insiders own 10.60% of the company’s stock.

More Veeva Systems News

Here are the key news stories impacting Veeva Systems this week:

• Positive Sentiment: Veeva’s strong second-quarter results, continued Vault CRM migrations and expansion of AI products support expectations for sustained growth. The company’s software remains deeply embedded in pharmaceutical and biotech workflows, creating customer retention and cross-selling opportunities. Reasons to Hold Veeva Systems Stock in Your Portfolio for Now
• Positive Sentiment: Veeva highlighted new AI capabilities, including Veeva Falcon and Vault AI, along with enhancements to its Development Cloud and Quality Cloud applications. These tools could increase the value of its platform as drug developers seek faster research, clinical-trial and quality processes. Veeva Systems Showcases AI Innovations
• Positive Sentiment: Veeva Basics has reached nearly 200 customers and the company is drawing attention after reaching approximately 175 biotech customers, signaling adoption among emerging biopharma companies and a potentially broader long-term customer base. Veeva Basics Customer Update
• Positive Sentiment: Market commentary identifies Veeva as one of the software companies benefiting from institutional buying after earlier fears that AI could make subscription software obsolete. Its sticky customer data and strong switching costs are viewed as competitive advantages. Wall Street Left Software for Dead
• Neutral Sentiment: Evercore ISI raised its price target from $185 to $250, but that target is below the stock’s recent trading level, suggesting analysts may see less near-term upside after the rally. Evercore ISI Adjusts Veeva Price Target
• Negative Sentiment: Investors remain concerned that market saturation could limit growth, while valuation-focused analysis estimates the shares may be roughly 11% above fair value based on future cash generation. Veeva’s sharp advance also leaves the stock vulnerable to profit-taking if adoption or earnings momentum slows. Veeva Stock May Be Below Fair Value

Veeva Systems Trading Up 4.0%

VEEV stock opened at $296.15 on Friday. The stock’s fifty day simple moving average is $261.01 and its two-hundred day simple moving average is $203.58. Veeva Systems Inc. has a 1-year low of $148.05 and a 1-year high of $302.17. The stock has a market cap of $47.95 billion, a P/E ratio of 48.71, a P/E/G ratio of 1.22 and a beta of 0.93.

Veeva Systems (NYSE:VEEV) last announced its quarterly earnings data on Wednesday, August 26th. The technology company reported $2.35 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.23 by $0.12. The firm had revenue of $927.96 million during the quarter, compared to the consensus estimate of $905.38 million. Veeva Systems had a return on equity of 14.25% and a net margin of 29.34%. The business’s revenue for the quarter was up 17.6% on a year-over-year basis. During the same quarter in the prior year, the company earned $1.99 EPS. Veeva Systems has set its FY 2027 guidance at 9.210-9.210 EPS and its Q3 2027 guidance at 2.330-2.340 EPS. As a group, analysts forecast that Veeva Systems Inc. will post 6.70 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

VEEV has been the topic of several analyst reports. Piper Sandler upped their price target on Veeva Systems from $295.00 to $320.00 and gave the stock an “overweight” rating in a report on Thursday, August 27th. Truist Financial lifted their price objective on shares of Veeva Systems from $262.00 to $305.00 and gave the stock a “buy” rating in a report on Thursday, August 27th. Stifel Nicolaus set a $300.00 target price on shares of Veeva Systems in a research note on Thursday, August 27th. Citigroup increased their target price on shares of Veeva Systems from $190.00 to $273.00 and gave the company a “neutral” rating in a report on Friday, August 28th. Finally, Needham & Company LLC raised their price target on shares of Veeva Systems from $270.00 to $310.00 and gave the company a “buy” rating in a research report on Thursday, August 27th. Nineteen analysts have rated the stock with a Buy rating, eight have issued a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat, the company presently has an average rating of “Moderate Buy” and an average price target of $284.88.

About Veeva Systems

Veeva Systems Inc is a cloud software company that provides applications and services for the life sciences industry. Its customers include pharmaceutical, biotechnology, medical device and other organizations involved in developing, manufacturing and commercializing regulated products.

The company’s product portfolio includes the Veeva Vault platform, which supports areas such as clinical operations, regulatory affairs, quality management, safety and medical communications. Veeva also offers commercial and customer relationship management applications, data and analytics products, and services designed to help life sciences companies manage relationships with healthcare professionals, oversee content and improve operational efficiency.

Founded in 2007, Veeva serves customers globally and has expanded its offerings from commercial software into research, development, manufacturing and quality processes.